Search filters
Filters
Clear All

Phase

  • 183
  • 156
  • 2
  • 194
  • 1
  • 148
  • 17
  • 396
  • 1237
  • 588
  • 29
  • 49
  • 3
  • 1162
  • 1237
  • 6
  • 3
  • 1240

Found 1243 All Conditions trials

A listing of All Conditions medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Linking Tau PET to Medial Temporal Lobe Subregions with High Resolution MRI

Linking Tau PET to Medial Temporal Lobe Subregions with High Resolution MRI

60 years - 99 years
All genders
The goal of this research is to collect Tau PET imaging in cognitively normal older adults and patients with Mild Cognitive Impairment (MCI) in the NACC study, to determine relationship to clinical, cognitive, and other biomarker data. Findings from this study will likely provide insight into the mechanisms and distinctions …
Learn More
UPenn Stent-Graft Study

UPenn Stent-Graft Study

18 years - 99 years
All genders
This study will assess the feasibility and safety and to evaluate clinical outcomes of endovascular repair of complex aortic aneurysms (thoracoabdominal aortic aneurysms and aortic arch aneurysms or TAAA) in patients at high risk for open surgery in two study arms. Participants that choose to sign the informed consent and …
Learn More
Hair Probe to Enhance Cerebral Optical Monitoring of Stroke

Hair Probe to Enhance Cerebral Optical Monitoring of Stroke

99 years or below
All genders
A novel device, developed at the University of Pennsylvania, utilizes diffuse correlation spectroscopy (DCS), which allows for real-time, continuous bedside monitoring of CBF using near infrared light. This non-invasive device holds great promise for monitoring cerebral hemodynamics in stroke patients. Prior work from our group has used this device to …
Learn More
Evaluation of Long-Axial Field-of-View Positron Emission Tomography (PET) Scanner

Evaluation of Long-Axial Field-of-View Positron Emission Tomography (PET) Scanner

18 years - 99 years
All genders
Normal 0 false false false EN-US X-NONE X-NONE The research study is being done to test the performance of a new type of whole-body imaging device called a Positron Emission Tomography (PET) long-axial field-of-view scanner, called the PennPET Explorer, that has been developed at the University of Pennsylvania and is …
Learn More
Study of INO-5401 Alone or INO-5401 in Combination with INO-9012 Followed by Electroporation in Adults with BRCA1 or BRCA2 Mutations

Study of INO-5401 Alone or INO-5401 in Combination with INO-9012 Followed by Electroporation in Adults with BRCA1 or BRCA2 Mutations

18 years - 99 years
All genders
Phase 1
The research study is being conducted to test an experimental vaccine to potentially prevent cancer for people with BRCA1 or BRCA2 mutations. This study will test if the vaccine is safe (without significant side effects) and test a new way of administering vaccines. It will also test whether the vaccine …
Learn More
UPCC 09220: Phase II Study of Telomelysin (OBP-301) in Combination with Pembrolizumab in Esophagogastric Adenocarcinoma

UPCC 09220: Phase II Study of Telomelysin (OBP-301) in Combination with Pembrolizumab in Esophagogastric Adenocarcinoma

99 years or below
All genders
Phase 2
The purpose of this study is to test the effects of the research study drug Telomelysin (OBP-301) in combination with pembrolizumab in advanced or metastatic gastric or gastroesophageal junction (GEJ) cancer. Eligible subjects are those with advanced or metastatic cancer of the stomach or junction between the stomach and esophagus.
Learn More
HCC Cholate- Hepatic functional deterioration after radiation therapy for hepatocellular carcinoma measured by hepatic cholate clearance

HCC Cholate- Hepatic functional deterioration after radiation therapy for hepatocellular carcinoma measured by hepatic cholate clearance

18 years - 99 years
All genders
Phase 1
In this study, subjects diagnosed with liver cancer undergo the HepQuant SHUNT diagnostic assay as a means to determine liver function. The results of this assay will potentially inform radiation treatment.
Learn More
Featured study
Adaptive Platform Treatment Trial for Outpatients with COVID-19 - ACTIV-2

Adaptive Platform Treatment Trial for Outpatients with COVID-19 - ACTIV-2

18 years - 100 years
All genders
Phase 2
The ACTIV-2 Study is testing an investigational medicine to see if they are safe and can help adults with COVID-19 get better.The type of investigational medicine you might receive in the study is a monoclonal antibody. Antibodies are naturally made by your body to help fight disease. Monoclonal antibodies are …
Check Eligibility

Imaging of Primary or Recurrent Breast Cancer with 18F-FluorThanatrace Positron Emission Tomography (PET/CT)

99 years or below
All genders
Phase 1
This study recruits participants directly from Penn Medicine clinics, during time of their clinical biopsies. Up to 40 participants with known or suspected primary or metastatic breast cancer who meet eligibility requirements for this study will undergo FTT PET/CT study imaging. Each PET/CT scan will include an injection of up …
Learn More
Phase II Trial of Pembrolizumab and Reirradiation in Bevacizumab Naive and Bevacizumab Resistant Recurrent Glioblastoma

Phase II Trial of Pembrolizumab and Reirradiation in Bevacizumab Naive and Bevacizumab Resistant Recurrent Glioblastoma

18 years - 99 years
All genders
Phase 2
This is a multicenter, open-label, phase II trial of pembrolizumab plus re-irradiation among recurrent glioblastoma patients enrolled to two parallel, non-comparative treatment arms including patients who are bevacizumab naïve (Arm A, n=30) and patients who are bevacizumab-resistant (Arm B, n=30). All subjects must have histologically confirmed World Health Organization (WHO) …
Learn More
931 - 940 of 1243